EVMN EBITDA Margin

Evommune, Inc. Common Stock · EBITDA Margin

EVMN logo

EVMN EBITDA Margin

Latest reported-1003.55%
EVMN TTM EBITDA Margin (-909.96% → -1003.55%)
High-resolution chart · PNG

EVMN ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Evommune, Inc. Common Stock EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-1,003.55%
-791.99%
-536.6923%
-448.7769%
-2,050.3333%
-2,512.3667%
-909.9571%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.